Advanced search
Publication Cover
International Journal of Nanomedicine Volume 8, 2013 - Issue
Submit an article Journal homepage
519
Views
59
CrossRef citations to date
0
Altmetric
Original Research

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s disease

Manal Fouad Ismail1 Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, EgyptCorrespondence[email protected]
,
Aliaa Nabil ElMeshad2 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt
&
Neveen Abdel-Hameed Salem3 Department of Narcotics and Ergogenic Aids and Poisons, National Research Center, Giza, Egypt
Pages 393-406 | Published online: 23 Jan 2013

Citations (59)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Pramod G. Nagaraju, Ashwini S & Poornima Priyadarshini. (2023) Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease. Critical Reviews in Food Science and Nutrition 63:32, pages 11153-11168.
Read now
Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, Seyed Zachariah Moradi, Mohammad Hosein Farzaei & Mohammad Abdollahi. (2022) Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases. International Journal of Nanomedicine 17, pages 299-331.
Read now
Oliver Lloyd-Parry, Charlotte Downing, Eisa Aleisaei, Celine Jones & Kevin Coward. (2018) Nanomedicine applications in women’s health: state of the art. International Journal of Nanomedicine 13, pages 1963-1983.
Read now
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Nobuhito Hamano, Shyh-Dar Li, Mahavir Chougule, Sunday A. Shoyele, Umesh Gupta, Ajazuddin & Amit Alexander. (2018) Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opinion on Drug Delivery 15:6, pages 589-617.
Read now
Débora B Vieira & Lionel F Gamarra. (2016) Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. International Journal of Nanomedicine 11, pages 5381-5414.
Read now
Bruno Fonseca-Santos, Maria Palmira Daflon Gremião & Marlus Chorilli. (2015) Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease. International Journal of Nanomedicine 10, pages 4981-5003.
Read now

Articles from other publishers (53)

Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, Fariborz Bahrehmand, Sajad Fakhri, Somayeh Kakehbaraei & Seyran Kakebaraei. (2023) Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review. IET Nanobiotechnology 17:3, pages 154-170.
Crossref
Xiu Han, Yan Lu, Zhaoluo Xu, Yanan Chu, Xueping Ma, Haiping Wu, Bingjie Zou & Guohua Zhou. (2023) Anionic liposomes prepared without organic solvents for effective siRNA delivery. IET Nanobiotechnology.
Crossref
Débora Nunes, Joana A. Loureiro & Maria Carmo Pereira. (2022) Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs. Pharmaceutics 14:11, pages 2296.
Crossref
Nancy Nabil Shahin, Rehab Nabil Shamma & Iman Saad Ahmed. (2022) A Nano-Liposomal Formulation of Caffeic Acid Phenethyl Ester Modulates Nrf2 and NF-κβ Signaling and Alleviates Experimentally Induced Acute Pancreatitis in a Rat Model. Antioxidants 11:8, pages 1536.
Crossref
Rubina Roy, Pallab Bhattacharya & Anupom Borah. (2022) Targeting the Pathological Hallmarks of Alzheimer’s Disease Through Nanovesicleaided Drug Delivery Approach. Current Drug Metabolism 23:9, pages 693-707.
Crossref
Philippe Delbreil, Jean-Michel Rabanel, Xavier Banquy & Davide Brambilla. (2022) Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings. Advanced Drug Delivery Reviews 187, pages 114397.
Crossref
Kajal Tak, Prashansa Sharma, Rekha Sharma, Vivek Dave, Smita Jain & Swapnil Sharma. (2022) One-pot hydrothermal green synthesis of Polygala tenuifolia mediated graphene quantum dots for acetylcholine esterase inhibitory activity. Journal of Drug Delivery Science and Technology 73, pages 103486.
Crossref
Mohammad Saeedi & Fatemeh Mehranfar. (2022) Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease. Recent Patents on Biotechnology 16:2, pages 102-121.
Crossref
Bwalya Angel Witika, Madan Sai Poka, Patrick Hulisani Demana, Scott Kaba Matafwali, Siyabonga Melamane, Sandile Maswazi Malungelo Khamanga & Pedzisai Anotida Makoni. (2022) Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics 14:4, pages 836.
Crossref
Samaneh Fateh Basharzad, Mehrdad Hamidi, Aziz Maleki, Zahra Karami, Hamed Mohamadpour & Mohammad Reza Saghatchi Zanjani. (2022) Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery. Brain Research 1781, pages 147786.
Crossref
Tânia M. T. Guimarães, Tânia Moniz, Cláudia Nunes, Maya Margaritova Zaharieva, Mila Kaleva, Krassimira Yoncheva, Hristo Najdenski, Sofia A. Costa Lima & Salette Reis. (2022) Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model. Pharmaceutics 14:4, pages 752.
Crossref
Akhilesh Dubey, Namdev Dhas, Anup Naha, Usha Rani, Ravi GS, Amitha Shetty, Chaithra R Shetty & Srinivas Hebbar. (2022) Cationic biopolymer decorated Asiatic Acid and Centella asiatica extract incorporated liposomes for treating early-stage Alzheimer’s disease: An In-vitro and In-vivo investigation. F1000Research 11, pages 1535.
Crossref
Raafat A. Abdel-Aal, Ola A. Hussein, Reham G. Elsaady & Lobna A. Abdelzaher. (2022) Naproxen as a potential candidate for promoting rivastigmine anti-Alzheimer activity against aluminum chloride-prompted Alzheimer's-like disease in rats; neurogenesis and apoptosis modulation as a possible underlying mechanism. European Journal of Pharmacology 915, pages 174695.
Crossref
Reshu Virmani, Tarun Virmani & Kamla Pathak. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery 315 339 .
Pallav Namdeo, Jinu Mathew & Ashish Garg. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases 223 242 .
Hendrik Nieraad, Nina Pannwitz, Natasja de Bruin, Gerd Geisslinger & Uwe Till. (2021) Hyperhomocysteinemia: Metabolic Role and Animal Studies with a Focus on Cognitive Performance and Decline—A Review. Biomolecules 11:10, pages 1546.
Crossref
Mingoo Bae, Seung Yon Han, Eun-Sun Kim, Byung Hoon You, Young-Mi Kim, Jungsook Cho, Young-Won Chin & Young Hee Choi. (2021) Effect of Water Extract of Mangosteen Pericarp on Donepezil Pharmacokinetics in Mice. Molecules 26:17, pages 5246.
Crossref
Ankit Tandon, Sangh J. Singh & Rajnish K. Chaturvedi. (2021) Nanomedicine against Alzheimer’s and Parkinson’s Disease. Current Pharmaceutical Design 27:12, pages 1507-1545.
Crossref
Pragya Prasanna & Arun Upadhyay. (2021) Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go. ACS Pharmacology & Translational Science 4:1, pages 74-95.
Crossref
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines 153 180 .
Sara Silva, António J. Almeida & Nuno Vale. (2021) Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review. Journal of Nanoparticle Research 23:1.
Crossref
Sara Hassan Omar, Rihab Osman, Wael Mamdouh, Hend Mohamed Abdel-Bar & Gehanne A.S. Awad. (2020) Bioinspired lipid-polysaccharide modified hybrid nanoparticles as a brain-targeted highly loaded carrier for a hydrophilic drug. International Journal of Biological Macromolecules 165, pages 483-494.
Crossref
Rasha R. Yossef, Mohamed F. Al-Yamany, Muhammed A. Saad & Ayman E. El-Sahar. (2020) Neuroprotective effects of vildagliptin on drug induced Alzheimer's disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways. European Journal of Pharmacology 889, pages 173612.
Crossref
Kajal Tak, Rekha Sharma, Vivek Dave, Smita Jain & Swapnil Sharma. (2020) Clitoria ternatea Mediated Synthesis of Graphene Quantum Dots for the Treatment of Alzheimer’s Disease . ACS Chemical Neuroscience 11:22, pages 3741-3748.
Crossref
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Niloufar Choubdar & Sara Avizheh. (2020) Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease. Nanoscience & Nanotechnology-Asia 10:3, pages 228-247.
Crossref
Thomas Adnet, Anne-Claire Groo, Céline Picard, Audrey Davis, Sophie Corvaisier, Marc Since, Frédéric Bounoure, Christophe Rochais, Loïc Le Pluart, Patrick Dallemagne & Aurélie Malzert-Fréon. (2020) Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment. Pharmaceutics 12:3, pages 251.
Crossref
Balmiki Ray, Bryan Maloney, Kumar Sambamurti, Hanuma K. Karnati, Peter T. Nelson, Nigel H. Greig & Debomoy K. Lahiri. (2020) Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease. Translational Psychiatry 10:1.
Crossref
Hossein Derakhshankhah, Soraya Sajadimajd, Samira Jafari, Zhila Izadi, Sajad Sarvari, Majid Sharifi, Mojtaba Falahati, Faezeh Moakedi, Willis Collins Akeyo Muganda, Mareike Müller, Mohammad Raoufi & John F. Presley. (2020) Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 24, pages 102149.
Crossref
Juhi Samal, Ana Lucia Rebelo & Abhay Pandit. (2019) A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders. Advanced Drug Delivery Reviews 148, pages 68-145.
Crossref
Paula dos Passos Menezes, Tatianny de Araújo Andrade, Luiza Abrahão Frank, Eloísa Portugal Barros Silva Soares de Souza, Gabriela das Graças Gomes Trindade, Igor Araújo Santos Trindade, Mairim Russo Serafini, Sílvia Stanisçuaski Guterres & Adriano Antunes de Souza Araújo. (2019) Advances of nanosystems containing cyclodextrins and their applications in pharmaceuticals. International Journal of Pharmaceutics 559, pages 312-328.
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases 65 138 .
Sushama Talegaonkar, Namrata Gautam, Venu Varshney, Sandeep Kumar Sharma & Arundhati Bhattacharyya. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases 307 341 .
Seiko Goto, Xuting Shen, Minkai Sun, Yutaka Hamano & Karl Herrup. (2018) The Positive Effects of Viewing Gardens for Persons with Dementia. Journal of Alzheimer's Disease 66:4, pages 1705-1720.
Crossref
Samar M. Etman, Yosra S. R. Elnaggar, Doaa A. Abdelmonsif & Ossama Y. Abdallah. (2018) Oral Brain-Targeted Microemulsion for Enhanced Piperine Delivery in Alzheimer’s Disease Therapy: In Vitro Appraisal, In Vivo Activity, and Nanotoxicity. AAPS PharmSciTech 19:8, pages 3698-3711.
Crossref
Muhammad Ovais, Nashmia Zia, Irshad Ahmad, Ali Talha Khalil, Abida Raza, Muhammad Ayaz, Abdul Sadiq, Farhat Ullah & Zabta Khan Shinwari. (2018) Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities. Frontiers in Aging Neuroscience 10.
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
S. Salatin, J. Barar, M. Barzegar-Jalali, Kh. Adibkia & M. Jelvehgari. (2017) Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies. Colloids and Surfaces B: Biointerfaces 159, pages 629-638.
Crossref
Ibrahim H. Borai, Magda K. Ezz, Maha Z. Rizk, Hanan F. Aly, Mahmoud El-Sherbiny, Azza A. Matloub & Ghadha I. Fouad. (2017) Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer’s disease. Biomedicine & Pharmacotherapy 93, pages 837-851.
Crossref
Shakeel Ahmed Ansari, Rukhsana Satar, Asma Perveen & Ghulam Md Ashraf. (2017) Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches. Current Opinion in Psychiatry 30:2, pages 128-135.
Crossref
Héloïse Proquin, Carolina Rodríguez-Ibarra, Carolyn G. J. Moonen, Ismael M. Urrutia Ortega, Jacob J. Briedé, Theo M. de Kok, Henk van Loveren & Yolanda I. Chirino. (2017) Titanium dioxide food additive (E171) induces ROS formation and genotoxicity: contribution of micro and nano-sized fractions. Mutagenesis 32:1, pages 139-149.
Crossref
Ming Ming Wen, Noha S. El-Salamouni, Wessam M. El-Refaie, Heba A. Hazzah, Mai M. Ali, Giovanni Tosi, Ragwa M. Farid, Maria J. Blanco-Prieto, Nashiru Billa & Amira S. Hanafy. (2017) Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release 245, pages 95-107.
Crossref
Sara Hernando, Oihane Gartziandia, Enara Herran, Jose Luis Pedraz, Manoli Igartua & Rosa Maria Hernandez. (2016) Advances in nanomedicine for the treatment of Alzheimer’s and Parkinson’s diseases. Nanomedicine 11:10, pages 1267-1285.
Crossref
Alice Simon, Maria Inês Amaro, Lucio Mendes Cabral, Anne Marie Healy & Valeria Pereira de Sousa. (2016) Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. International Journal of Pharmaceutics 501:1-2, pages 124-138.
Crossref
A.M. Cardoso, J.R. Guedes, A.L. Cardoso, C. Morais, P. Cunha, A.T. Viegas, R. Costa, A. Jurado & M.C. Pedroso de Lima. 2016. Nanotechnology and the Brain. Nanotechnology and the Brain 1 40 .
Maria Inês Amaro, Alice Simon, Lúcio Mendes Cabral, Valéria Pereira de Sousa & Anne Marie Healy. (2015) Rivastigmine hydrogen tartrate polymorphs: Solid-state characterisation of transition and polymorphic conversion via milling. Solid State Sciences 49, pages 29-36.
Crossref
Marc-Antoine Lauzon, Alex Daviau, Bernard Marcos & Nathalie Faucheux. (2015) Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease. Journal of Controlled Release 206, pages 187-205.
Crossref
Lucia Migliore, Chiara Uboldi, Sebastiano Di Bucchianico & Fabio Coppedè. (2015) Nanomaterials and neurodegeneration. Environmental and Molecular Mutagenesis 56:2, pages 149-170.
Crossref
Xiao Gu, Hongzhuan Chen & Xiaoling Gao. (2015) Nanotherapeutic strategies for the treatment of Alzheimer's disease. Therapeutic Delivery 6:2, pages 177-195.
Crossref
Shyamasree Ghosh & Waliza Ansar. 2015. Nanoparticles' Promises and Risks. Nanoparticles' Promises and Risks 167 210 .
Shravan Kumar Sriraman & Vladimir P. Torchilin. 2014. Advanced Biomaterials and Biodevices. Advanced Biomaterials and Biodevices 79 119 .
Toral R Patel. (2014) Nanocarrier-based therapies for CNS tumors. CNS Oncology 3:2, pages 115-122.
Crossref
Rebecca Zhangqiuzi Fan, Dan Fei, Roberta D’Aurelio & Yi Ge. 2014. Nanomedicine. Nanomedicine 355 364 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.